Editorial|Volume 8, Issue 7|pp 1292—1293 Lymphoid malignancies ARNT unstoppable
Kacie A. Gardella2Institute for Cellular and Molecular Biology, The University of Texas at Austin, Austin, TX 78712, USA, Richa Tiwary1Division of Pharmacology and Toxicology, and the Center for Molecular and Cellular Toxicology, College of Pharmacy, The University of Texas at Austin, Austin, TX 78712, USA, Casey W. Wright1,Division of Pharmacology and Toxicology, and the Center for Molecular and Cellular Toxicology, College of Pharmacy, The University of Texas at Austin, Austin, TX 78712, USA2Institute for Cellular and Molecular Biology, The University of Texas at Austin, Austin, TX 78712, USA
- 1Division of Pharmacology and Toxicology, and the Center for Molecular and Cellular Toxicology, College of Pharmacy, The University of Texas at Austin, Austin, TX 78712, USA
- 2Institute for Cellular and Molecular Biology, The University of Texas at Austin, Austin, TX 78712, USA
Received: July 2, 2016Published: July 26, 2016
Copyright: © 2016 Gardella et al.
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
